FGEN Dividend: FibroGen Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

FGEN Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	8	29	46	140	235	176
Revenue Growth (YoY)	-96%	-37%	-67%	-40%	34%	-31%
Cost of Revenue	-20	15	3	20	12	8
Gross Profit	28	14	42	120	222	167
Selling, General & Admin	7	50	89	127	120	97
Research & Development	17	95	266	296	387	252
Operating Expenses	151	145	352	421	510	359
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-128	-153	-323	-294	-290	-188
Income Tax Expense	0	0	0	0	0	0
Net Income	215	-47	-284	-293	-290	-189
Net Income Growth	-278%	-83%	-3%	1%	53%	145%
Shares Outstanding (Diluted)	4.04	4	3.89	3.74	3.69	3.59
Shares Change (YoY)	1%	3%	4%	1%	3%	4%
EPS (Diluted)	53.32	-11.88	-73.02	-78.46	-78.5	-52.66
EPS Growth	-276%	-84%	-7%	0%	49%	137%
Free Cash Flow	-17	-138	-317	-184	-112	77
Free Cash Flow Per Share	-4.2	-34.48	-81.44	-49.15	-30.31	21.42
Gross Margin	350%	48.27%	91.3%	85.71%	94.46%	94.88%
Operating Margin	-1,525%	-448.27%	-673.91%	-215%	-122.55%	-108.52%
Profit Margin	2,687.5%	-162.06%	-617.39%	-209.28%	-123.4%	-107.38%
Free Cash Flow Margin	-212.5%	-475.86%	-689.13%	-131.42%	-47.65%	43.75%
EBITDA	-121	-128	-301	-301	-284	-181
EBITDA Margin	-1,512.5%	-441.37%	-654.34%	-215%	-120.85%	-102.84%
D&A For EBITDA	1	2	9	0	4	10
EBIT	-122	-130	-310	-301	-288	-191
EBIT Margin	-1,525%	-448.27%	-673.91%	-215%	-122.55%	-108.52%
Effective Tax Rate	0%	0%	0%	0%	0%	0%